Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D69KBS
|
|||
| Drug Name |
ASP7317
|
|||
| Drug Type |
Cell therapy
|
|||
| Indication | Age-related macular degeneration [ICD-11: 9B75.0; ICD-10: H35] | Phase 1 | [1] | |
| Company |
Astellas Pharma
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT03178149) A Study of the Safety and Tolerability of ASP7317 in Adults Who Are Losing Their Clear, Sharp Central Vision Due to Geographic Atrophy Secondary to Dry Age-related Macular Degeneration. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.